Northwestern Medicine investigators have uncovered new insights into how metabolic dysfunction contributes to Parkinson's ...

Professor Lezanne Ooi awarded close to $400k for new study to understand links between environmental toxins and debilitating ...

People with Parkinson's don't have enough of the chemical dopamine in their brain, because some of the nerve cells that make ...

The risk of developing Parkinson's disease is twice as high in men as in women, and new research points to a potential reason ...

Parkinson’s disease (PD) affects nearly 2% of adults over 65, making it the second most common neurodegenerative disorder. It ...

A Scottish woman who has an extremely rare ability to smell Parkinson's disease revealed what she smelt on her husband years ...

More advanced methods may enable better modelling Parkinson’s disease is a considerable health problem owing to its high and rising global prevalence, its progressively degenerative nature, and its ...

Annovis Bio Inc. (NYSE: ANVS) ("Annovis"), a late-stage clinical drug platform company pioneering transformative therapies ...

A recent study titled AI-Enabled Conversational Journaling for Advancing Parkinson’s Disease Symptom Tracking, authored by ...

Scientists have identified a rare genetic mutation in ITSN1 that increases the risk of Parkinson’s disease by up to tenfold, ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

A team of scientists has revealed a breakthrough discovery, linking genetic variants in the gene ITSN1 to a significantly ...